Ikena Oncology, Inc. IKNA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

1/6 Pass

SharesGrow Intrinsic Value

Stock Statistics — IKNA

Ikena Oncology, Inc. (IKNA) has a market capitalization of $718.82M and trades at $17.16. The 52-week range is 1.36-23.28.

The stock has a beta of 0.50, operates in the Healthcare sector.

Trading Data

Current Price$17.16

52-Week Range1.36-23.28

Volume457.26K

Avg Volume (30D)18K

Market Cap$718.82M

Beta (1Y)0.50

Company

IPO Date2021-03-26

Employees10

CEOMark Manfredi

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS45175G1085

CUSIP45175G108

Income (Latest Year)

EBITDA$-48.45M

Operating Income$-48.45M

Net Income$-52.4M

Balance Sheet (Latest Year)

Total Assets$82.81M

Current Assets$75.79M

Cash & ST Investments$75.79M

Total Liabilities$7.02M

Net Debt$-34.97M

Total Equity$75.79M

Valuation Ratios

P/B Ratio9.49

People Also View

KYMR

Kymera Therapeutics, Inc.

Edgewise Therapeutics, Inc.

$33.16

-2.01%

STOK

Stoke Therapeutics, Inc.

$35.86

+2.31%

NRIX

Nurix Therapeutics, Inc.

$16.30

+2.45%

GLUE

Monte Rosa Therapeutics, Inc.

$17.50

-0.28%

DSGN

Design Therapeutics, Inc.

$12.64

+2.35%

ELYM

Eliem Therapeutics, Inc.

$5.11

-0.97%

Ikena Oncology, Inc. IKNA NASDAQ

Stock Statistics — IKNA

People Also View

Get Undervalued Stock Alerts